EZH2 and neoplasm: It was also shown that EZH2 is overexpressed in OSCC cell lines and primary tumours, and that a genetic or pharmacological inhibition of EZH2 attenuates tumour growth and restores differentiation gene expression in differentiation refractory OSCC xenografts [64].